Back to News
Market Impact: 0.35

Canaccord Genuity Maintains Artivion (AORT) Buy Recommendation

AORTDCCAXIJR
Analyst EstimatesAnalyst InsightsCorporate EarningsCompany FundamentalsInvestor Sentiment & PositioningMarket Technicals & FlowsFutures & Options
Canaccord Genuity Maintains Artivion (AORT) Buy Recommendation

Canaccord Genuity maintained a "Buy" rating on Artivion (AORT), setting an average one-year price target of $46.16, which implies a 2.88% upside from its current $44.87. This positive analyst outlook comes despite a projected 6.52% decrease in annual revenue to $395MM, yet institutional sentiment remains bullish, evidenced by a 6.70% increase in funds holding AORT, a 13.40% rise in average portfolio weight, and a low put/call ratio of 0.18.

Analysis

Canaccord Genuity reiterated a "Buy" rating for Artivion (AORT) on November 7, 2025, setting an average one-year price target of $46.16. This target implies a modest 2.88% upside from the recent closing price of $44.87, despite the company projecting a 6.52% decrease in annual revenue to $395MM and a non-GAAP EPS of $0.02. The analyst's positive stance is noteworthy given these mixed fundamental projections. Despite the anticipated revenue decline, institutional sentiment towards AORT remains notably bullish. The number of funds reporting positions increased by 6.70% (29 owners) last quarter, bringing the total to 462. Furthermore, the average portfolio weight dedicated to AORT rose by 13.40%, and total institutional shares owned grew by 2.11% to 53,672K shares over the last three months. The options market reinforces this bullish outlook, indicated by a low put/call ratio of 0.18. Several major institutional holders, including Macquarie Group and Delaware Small Cap Core Fund (DCCAX), significantly increased their portfolio allocation in AORT by 27.29% and 27.38% respectively, alongside increases in their shareholdings. This suggests strong conviction among institutional players despite some firms, like IJR and Juniper, slightly reducing their share count while increasing portfolio allocation.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo